About this episode
Dr Jake and David review 2021, another year ravaged by COVID and lockdowns, and share how disruptive it has been behind the scenes. They revisit the predictions they made in Episode 141 about what the Australian injectables industry would look like after lockdown.
They discuss staffing shortages, rising costs and wages, managing demand and long wait times, patient expectations and complaints, burnout and retention, post-lockdown recovery, whether clinics should raise prices, training standards for new injectors, regulation, and upcoming guests, new series and video plans for 2022.
What you'll learn
- How lockdowns reshaped the industry
- Managing staffing shortages and burnout
- Whether to raise prices during high demand
- What's coming on the podcast in 2022
Topics
- Hosts
- Industry trends
- Staffing
- Pricing
- Australia
Full transcript
The full transcript for this episode is coming soon.